PROK ProKidney Corp
Price (delayed)
$0.9902
Market cap
$289.83M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.62
Enterprise value
$193.95M
Highlights
ProKidney's debt has decreased by 50% from the previous quarter and by 27% YoY
ProKidney's equity has increased by 10% YoY
The net income has dropped by 73% year-on-year and by 34% since the previous quarter
PROK's quick ratio is down by 39% QoQ and by 32% YoY
Key stats
What are the main financial stats of PROK
Market
Valuations
Earnings
Shares outstanding
292.7M
Market cap
$289.83M
Enterprise value
$193.95M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1,275.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2,551.91
Revenue
$76,000
Gross profit
$76,000
Operating income
-$183.68M
Net income
-$61.19M
EBIT
-$61.78M
EBITDA
-$56.34M
Free cash flow
-$155.86M
Per share
Balance sheet
Liquidity
EPS
-$0.62
EPS diluted
-$0.62
Free cash flow per share
-$1.59
Book value per share
-$3.41
Revenue per share
$0
TBVPS
$4.5
Total assets
$441.07M
Total liabilities
$39.44M
Debt
$3.24M
Equity
-$994.95M
Working capital
$359.67M
Debt to equity
0
Current ratio
10.93
Quick ratio
9.89
Net debt/EBITDA
1.7
Margins
Efficiency
Dividend
EBITDA margin
-74,135.5%
Gross margin
100%
Net margin
-80,507.9%
Operating margin
-241,678.9%
Return on assets
-13.6%
Return on equity
N/A
Return on invested capital
-20.3%
Return on capital employed
-15.3%
Return on sales
-81,282.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PROK stock price
How has the ProKidney stock price performed over time
Intraday
8.8%
1 week
25.2%
1 month
-2.92%
1 year
-63.46%
YTD
-41.41%
QTD
13.01%
Financial performance
How have ProKidney's revenue and profit performed over time
Revenue
$76,000
Gross profit
$76,000
Operating income
-$183.68M
Net income
-$61.19M
Gross margin
100%
Net margin
-80,507.9%
The net income has dropped by 73% year-on-year and by 34% since the previous quarter
ProKidney's operating income has decreased by 21% YoY and by 18% from the previous quarter
Growth
What is ProKidney's growth rate over time
Valuation
What is ProKidney stock price valuation
P/E
N/A
P/B
N/A
P/S
1,275.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2,551.91
The EPS has declined by 13% since the previous quarter and by 9% year-on-year
ProKidney's equity has increased by 10% YoY
Efficiency
How efficient is ProKidney business performance
The return on assets has dropped by 77% year-on-year and by 33% since the previous quarter
The return on invested capital has dropped by 75% year-on-year and by 40% since the previous quarter
Dividends
What is PROK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PROK.
Financial health
How did ProKidney financials performed over time
PROK's quick ratio is down by 39% QoQ and by 32% YoY
The current ratio has declined by 36% since the previous quarter and by 27% year-on-year
ProKidney's debt is 100% more than its equity
The debt to equity has soared by 100% since the previous quarter
ProKidney's debt has decreased by 50% from the previous quarter and by 27% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.